XML 72 R51.htm IDEA: XBRL DOCUMENT v3.6.0.2
ALLIANCES (Otsuka) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Alliances Statement [Line Items]                        
Net product sales                 $ 17,702 $ 14,045 $ 11,660  
Alliance revenues                 1,725 2,515 4,219  
Total Revenues $ 5,243 $ 4,922 $ 4,871 $ 4,391 $ 4,287 $ 4,069 $ 4,163 $ 4,041 19,427 16,560 15,879  
Abilify [Member]                        
Alliances Statement [Line Items]                        
Total Revenues                 128 $ 746 $ 2,020  
Otsuka [Member]                        
Alliances Statement [Line Items]                        
Percentage of net sales recognized from alliance         50.00%         50.00% 33.00%  
Net product sales                 1,670 $ 1,501 $ 1,493  
Alliance revenues                 2 604 1,778  
Total Revenues                 1,672 2,105 3,271  
Cost of products sold - Cost of product supply                 30 35 67  
Amortization of the extension payment                   21 66  
Otsuka [Member] | United States [Member] | Abilify [Member]                        
Alliances Statement [Line Items]                        
Cost of products sold - Royalties                 $ 10 30 90  
Otsuka [Member] | European Union [Member] | Abilify [Member]                        
Alliances Statement [Line Items]                        
Percentage of net sales recognized from alliance 65.00%               65.00%      
Otsuka [Member] | Oncology Territory [Member] | Sprycel and Ixempra [Member]                        
Alliances Statement [Line Items]                        
Cost of products sold - Oncology fee                 $ 304 $ 299 $ 297  
Otsuka [Member] | Oncology Territory [Member] | Sprycel and Ixempra [Member] | Operating expense up to $175 million [Member]                        
Alliances Statement [Line Items]                        
Percentage of operating expense reimbursements from alliance 20.00%               20.00%      
Amount of operating expense at or below which alliance partner will reimburse given percentage $ 175               $ 175      
Otsuka [Member] | Oncology Territory [Member] | Sprycel and Ixempra [Member] | Operating expenses over $175 million [Member]                        
Alliances Statement [Line Items]                        
Percentage of operating expense reimbursements from alliance 1.00%               1.00%      
Amount of operating expense over which alliance partner will reimburse given percentage $ 175               $ 175      
Otsuka [Member] | Oncology Territory [Member] | Sprycel and Ixempra [Member] | Annual net sales up to $400 million [Member]                        
Alliances Statement [Line Items]                        
Percentage of net sales payable to alliance partner 65.00%               65.00%     30.00%
Range of sales at which a given percentage will be paid to alliance partner - maximum                 $ 400      
Otsuka [Member] | Oncology Territory [Member] | Sprycel and Ixempra [Member] | Annual net sales between $400 and $600 million [Member]                        
Alliances Statement [Line Items]                        
Percentage of net sales payable to alliance partner 12.00%               12.00%     5.00%
Range of sales at which a given percentage will be paid to alliance partner - minimum                 $ 400      
Range of sales at which a given percentage will be paid to alliance partner - maximum                 $ 600      
Otsuka [Member] | Oncology Territory [Member] | Sprycel and Ixempra [Member] | Annual net sales between $600 and $800 million [Member]                        
Alliances Statement [Line Items]                        
Percentage of net sales payable to alliance partner 3.00%               3.00%     3.00%
Range of sales at which a given percentage will be paid to alliance partner - minimum                 $ 600      
Range of sales at which a given percentage will be paid to alliance partner - maximum                 $ 800      
Otsuka [Member] | Oncology Territory [Member] | Sprycel and Ixempra [Member] | Annual net sales between $800 million and $1 billion [Member]                        
Alliances Statement [Line Items]                        
Percentage of net sales payable to alliance partner 2.00%               2.00%     2.00%
Range of sales at which a given percentage will be paid to alliance partner - minimum                 $ 800      
Range of sales at which a given percentage will be paid to alliance partner - maximum                 $ 1,000      
Otsuka [Member] | Oncology Territory [Member] | Sprycel and Ixempra [Member] | Annual net sales over $1 billion [Member]                        
Alliances Statement [Line Items]                        
Percentage of net sales payable to alliance partner 1.00%               1.00%     1.00%
Range of sales at which a given percentage will be paid to alliance partner - minimum                 $ 1,000